Cargando…

A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization

Commercialization within the academic setting is associated with many challenges and barriers. Previous studies investigating these challenges/barriers have, in general, broadly focused on multiple disciplines and, oftentimes, several institutions simultaneously. The goal of the study presented here...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanderford, Nathan L., Weiss, L. Todd, Weiss, Heidi L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749229/
https://www.ncbi.nlm.nih.gov/pubmed/23991077
http://dx.doi.org/10.1371/journal.pone.0072268
_version_ 1782281173986181120
author Vanderford, Nathan L.
Weiss, L. Todd
Weiss, Heidi L.
author_facet Vanderford, Nathan L.
Weiss, L. Todd
Weiss, Heidi L.
author_sort Vanderford, Nathan L.
collection PubMed
description Commercialization within the academic setting is associated with many challenges and barriers. Previous studies investigating these challenges/barriers have, in general, broadly focused on multiple disciplines and, oftentimes, several institutions simultaneously. The goal of the study presented here was to analyze a range of barriers that may be broadly associated with commercializing academic-based cancer research. This goal was addressed via a study of the barriers associated with cancer research commercialization at the University of Kentucky (UK). To this end, a research instrument in the form of an electronic survey was developed. General demographic information was collected on study participants and two research questions were addressed: 1) What are the general barriers inhibiting cancer research commercialization at UK? and 2) Would mitigation of the barriers potentially enhance faculty engagement in commercialization activities? Descriptive and statistical analysis of the data reveal that multiple barriers likely inhibit cancer research commercialization at UK with expense, time, infrastructure, and lack of industry partnerships being among the most commonly cited factors. The potential alleviation of these factors in addition to revised University policies/procedures, risk mitigation, more emphasis on commercialization by academia research field, and increased information on how to commercialize significantly correlated with the potential for increased commercialization activity. Furthermore, multivariate logistic regression modeling demonstrated that research commercialization would incrementally increase as barriers to the process are removed and that PhD-holding respondents and respondents in commercialization-supportive research fields would be more likely to commercialize their research upon barrier removal. Overall, as with other disciplines, these data suggest that for innovations derived from academic cancer-research to move more effectively and efficiently into the marketplace, university administrators and external agents, such as policymakers, need to address what are well-documented and defined issues.
format Online
Article
Text
id pubmed-3749229
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37492292013-08-29 A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization Vanderford, Nathan L. Weiss, L. Todd Weiss, Heidi L. PLoS One Research Article Commercialization within the academic setting is associated with many challenges and barriers. Previous studies investigating these challenges/barriers have, in general, broadly focused on multiple disciplines and, oftentimes, several institutions simultaneously. The goal of the study presented here was to analyze a range of barriers that may be broadly associated with commercializing academic-based cancer research. This goal was addressed via a study of the barriers associated with cancer research commercialization at the University of Kentucky (UK). To this end, a research instrument in the form of an electronic survey was developed. General demographic information was collected on study participants and two research questions were addressed: 1) What are the general barriers inhibiting cancer research commercialization at UK? and 2) Would mitigation of the barriers potentially enhance faculty engagement in commercialization activities? Descriptive and statistical analysis of the data reveal that multiple barriers likely inhibit cancer research commercialization at UK with expense, time, infrastructure, and lack of industry partnerships being among the most commonly cited factors. The potential alleviation of these factors in addition to revised University policies/procedures, risk mitigation, more emphasis on commercialization by academia research field, and increased information on how to commercialize significantly correlated with the potential for increased commercialization activity. Furthermore, multivariate logistic regression modeling demonstrated that research commercialization would incrementally increase as barriers to the process are removed and that PhD-holding respondents and respondents in commercialization-supportive research fields would be more likely to commercialize their research upon barrier removal. Overall, as with other disciplines, these data suggest that for innovations derived from academic cancer-research to move more effectively and efficiently into the marketplace, university administrators and external agents, such as policymakers, need to address what are well-documented and defined issues. Public Library of Science 2013-08-21 /pmc/articles/PMC3749229/ /pubmed/23991077 http://dx.doi.org/10.1371/journal.pone.0072268 Text en © 2013 Vanderford et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Vanderford, Nathan L.
Weiss, L. Todd
Weiss, Heidi L.
A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
title A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
title_full A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
title_fullStr A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
title_full_unstemmed A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
title_short A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
title_sort survey of the barriers associated with academic-based cancer research commercialization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749229/
https://www.ncbi.nlm.nih.gov/pubmed/23991077
http://dx.doi.org/10.1371/journal.pone.0072268
work_keys_str_mv AT vanderfordnathanl asurveyofthebarriersassociatedwithacademicbasedcancerresearchcommercialization
AT weissltodd asurveyofthebarriersassociatedwithacademicbasedcancerresearchcommercialization
AT weissheidil asurveyofthebarriersassociatedwithacademicbasedcancerresearchcommercialization
AT vanderfordnathanl surveyofthebarriersassociatedwithacademicbasedcancerresearchcommercialization
AT weissltodd surveyofthebarriersassociatedwithacademicbasedcancerresearchcommercialization
AT weissheidil surveyofthebarriersassociatedwithacademicbasedcancerresearchcommercialization